Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 39 - Medicinal preparations containing antigens or antibodies
Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
04/2012
04/10/2012US8153777 Modulation of toll-like receptor 5 expression by antisense oligonucleotides
04/10/2012US8153775 Kits for detecting rank
04/10/2012US8153768 Complex of antibodic and antibiotic with carrier
04/10/2012US8153592 Modulating toll-like receptor activity
04/10/2012US8153580 Nogo receptor binding protein
04/10/2012US8153414 Microbial delivery system
04/10/2012US8153398 Polynucleotides encoding signal peptide-containing molecules
04/10/2012US8153384 Marks as modifiers of the p53 pathway and methods of use
04/10/2012US8153360 Flavivirus fusion inhibitors
04/10/2012US8153141 Immunostimulatory G, U-containing oligoribonucleotides
04/10/2012US8153140 Chimeric MSP-based malaria vaccine
04/10/2012US8153139 Treatment of rosacea with clostridia neurotoxins
04/10/2012US8153138 Recombinant MVA virus
04/10/2012US8153136 Yeast-based vaccines as immunotherapy
04/10/2012US8153135 Polysaccharide-polypeptide conjugate
04/10/2012US8153134 Anti-MDL-1 antibodies
04/10/2012US8153133 High potency recombinant antibodies and method for producing them
04/10/2012US8153131 High affinity antibodies against HMGB1 and methods of use thereof
04/10/2012US8153130 Graft-versus-host disease predicting marker and use thereof
04/10/2012US8153129 Antibodies against human cytimegalovirus (HCMV)
04/10/2012US8153128 Antibodies specific for the complex of interleukin-6 and the interleukin-6 receptor
04/10/2012US8153127 Method of treating depression
04/10/2012US8153126 Anti-αvβ6 antibodies
04/10/2012US8153125 CD20 binding molecules
04/10/2012US8153124 Method for treating cancer using monoclonal antibodies
04/10/2012US8153123 Method for restoring dendritic cell populations
04/10/2012US8153122 Pharmaceutical composition for treating cholangiocarcinoma, a method for inhibiting growth or invasion of cholangiocarcinoma and a method for treating cholangiocarcinoma
04/10/2012US8153121 Multiple sclerosis; Crohn's disease
04/10/2012US8153120 Methods for inducing a natural killer (NK) cell-mediated immune response and for increasing NK cell activity
04/10/2012US8153116 Use of conditional plasmodium strains lacking an essential gene in malaria vaccination
04/10/2012US8153115 Virus-like particles for treatment of viral infections
04/10/2012US8153114 Hyperglycosylated mammalian IL-7 IgG conjugate composition
04/10/2012US8153113 Method of increasing trafficking of endothelial progenitor cells to ischemia-damaged tissue
04/10/2012US8153102 Process for manufacturing pharmaceutical composition comprises of Mycobacterium w in the treatment of asthma (obstructive lung disease)
04/10/2012CA2486282C Virus-like particles, methods of preparation, and immunogenic compositions
04/10/2012CA2473754C Treatment of ms with goat serum
04/10/2012CA2468496C Ilk inhibitors for the treatment of renal disease
04/10/2012CA2445253C Single chain camelid vhh antibodies, method for their production in a mammal, and their uses
04/10/2012CA2438921C Streptococcus pyogenes polypeptides and corresponding dna fragments
04/10/2012CA2412035C Hcv antigen/antibody combination assay
04/10/2012CA2399432C Cytotoxic t lymphocytes activated by dendritic cell hybrids
04/10/2012CA2385325C Chlamydia antigens and corresponding dna fragments and uses thereof
04/10/2012CA2352783C Stimulation of t cells against self antigens using ctla-4 blocking agents
04/10/2012CA2263503C Melanoma cell lines expressing shared immunodominant melanoma antigens and methods of using same
04/05/2012WO2012045085A1 Anti-rori antibodies
04/05/2012WO2012045082A2 Engineered nucleic acids and methods of use thereof
04/05/2012WO2012045067A2 Mammalian genes involved in infection
04/05/2012WO2012045063A2 Flavivirus domain iii vaccine
04/05/2012WO2012045001A2 Influenza virus antibodies and immunogens and uses therefor
04/05/2012WO2012044999A2 Reversible protein multimers, methods for their production and use
04/05/2012WO2012044960A1 Enhancement of immune response by transfer factor
04/05/2012WO2012044893A1 Polypeptides that bind to human complement component c5
04/05/2012WO2012044612A1 Generation, characterization and uses thereof of anti-her3 antibodies
04/05/2012WO2012044162A1 Fat composition for programming immune response
04/05/2012WO2012043747A1 Glioma treatment method, glioma examination method, method of delivering a desired material to a glioma, and drug used in said methods
04/05/2012WO2012043634A1 Antibody against human prostaglandin e2 receptor ep4
04/05/2012WO2012043533A1 Antihuman ccr7 antibodies, hybridoma, nucleic acid, vector, cell, medicinal composition, and antibody-immobilized carrier
04/05/2012WO2012042857A1 Mucosal adjuvant composition
04/05/2012WO2012042540A2 Anticancer agent
04/05/2012WO2012042421A1 Method of treating abnormal cell growth
04/05/2012WO2012042289A1 Methods and pharmaceutical compositions for the treatment of bone density related diseases
04/05/2012WO2012042279A2 Viral vector immunogenic compositions
04/05/2012WO2012042003A1 Improved vaccine compositions
04/05/2012WO2012041968A1 Methods for treating autoimmune disease using biocompatible bioabsorbable nanospheres
04/05/2012WO2012041899A1 Fusion protein for secretory protein expression
04/05/2012WO2012041867A2 Combined antigen and dna vaccine for preventing and treating autoimmune diseases
04/05/2012WO2012041842A1 Vaccine
04/05/2012WO2012041800A1 Anti-cd38 antibody and lenalidomide or bortezomib for the treatment of multiple myeloma and nhl
04/05/2012WO2012041768A1 Production of low fucose antibodies in h4-ii-e rat cells
04/05/2012WO2012041669A1 Heterologous prime boost vaccination regimen against malaria
04/05/2012WO2012041635A1 Combination of an agonistic anti-cd40 monoclonal antibody or a cd40 ligand and inactivated or attenuated bacteria for use in the treatment and/or prevention of mastitis
04/05/2012WO2012041503A1 Generation of virosome particles
04/05/2012WO2012041260A1 .vaccine composition for controlling ectoparasite infestations
04/05/2012WO2012041018A1 ANTI TNF α HUMANIZED ANTIBODY AND FRAGMENT ANTIGEN BINDING (FAB) AND USE THEREOF
04/05/2012WO2012040824A1 Anti-ceacam6 antibodies and uses thereof
04/05/2012WO2012040806A2 Synergistic immunogenic compositions based on protein antigens combined with pertussis cell antigen and inactivated toxins
04/05/2012WO2012017328A3 Combination pharmaceutical composition and methods of treating and preventing the infectious diseases
04/05/2012WO2012009544A3 Domain insertion immunoglobulin
04/05/2012WO2011163566A3 Methods of treating patients with immune-related diseases
04/05/2012WO2011163446A3 Pan-lyssavirus vaccines against rabies
04/05/2012WO2011160132A3 Detection of epha3 as a marker of the presence of a solid tumor
04/05/2012WO2011153380A3 Humanized monoclonal antibodies and methods of use
04/05/2012WO2011150281A3 A compositon for neurological or autoimmune diseases
04/05/2012WO2011150279A3 Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of glutaminyl-trna synthetases
04/05/2012WO2011149955A3 Therapeutic method and composition
04/05/2012WO2011146410A3 Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of leucyl-trna synthetases
04/05/2012WO2011143482A3 Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of phenylalanyl-beta-trna synthetases
04/05/2012WO2011140295A3 Modulators of notch receptor signaling and methods of use thereof
04/05/2012WO2011140135A3 Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of methionyl-trna synthetases
04/05/2012WO2011139988A3 Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of seryl-trna synthetases
04/05/2012WO2011139799A3 Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of isoleucyl trna synthetases
04/05/2012WO2011139714A3 Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of cysteinyl-trna synthetase
04/05/2012WO2011133867A3 Vaccines, methods of administering vaccines, methods and products for treating and/or delaying onset of dysplastic lesions, and wafers for oral administration
04/05/2012WO2011127324A3 Antibodies to cd122
04/05/2012WO2011119979A3 Antibodies to muc16 and methods of use thereof
04/05/2012WO2011116226A3 Display of antibody fragments on virus-like particles of rna bacteriophages
04/05/2012US20120084871 Npc1l1 orthologues
04/05/2012US20120083588 Neutral amino acid transporter and gene thereof
04/05/2012US20120082732 Medicine for treatment of a carcinoma
04/05/2012US20120082730 Nanoparticulate in-situ gels as vitreous humor substitutes for ocular diseases
1 ... 290 291 292 293 294 295 296 297 298 299 300 301 302 303 304 305 306 307 308 309 310 ... 1823